EODData

MEMBERSHIP REGISTER LOG IN

NASDAQ, XERS: Xeris Pharmaceuticals Inc

18 Dec 25 15:59
LAST:

7.000

CHANGE:
 0.02		OPEN:
7.100		HIGH:
7.210		ASK:
0.000		VOLUME:
817.5K
CHG(%):
0.29		PREV:
6.990		LOW:
6.990		BID:
0.000		 

CHART

RECENT END OF DAY PRICES

DateOpenHighLowCloseVolume
18 Dec 257.1007.2106.9907.0101.96M
17 Dec 257.0607.2606.9706.9901.04M
16 Dec 257.0207.1556.9507.1001.93M
15 Dec 257.1707.2507.0207.0501.68M
12 Dec 257.0907.2007.0007.1701.72M
11 Dec 256.9407.2456.8957.0102.15M
10 Dec 257.0307.0706.8546.9402.44M
09 Dec 257.0607.3006.9507.0103.29M
08 Dec 256.6707.0606.5666.9902.66M
05 Dec 256.7506.8006.4706.5102.04M

PROFILE

Name:Xeris Pharmaceuticals Inc
About:Xeris Biopharma Holdings, Inc., a commercial-stage biopharmaceutical company, engages in developing and commercializing therapies for chronic endocrine and neurological diseases in Illinois. The company offers Gvoke, a ready-to-use liquid-stable glucagon for the treatment of severe hypoglycemia in pediatric and adult patients; Keveyis, a therapy for the treatment of hyperkalemic, hypokalemic, and related variants of primary periodic paralysis; and Recorlev, a cortisol synthesis inhibitor for the treatment of endogenous hypercortisolemia in adult patients with Cushing's syndrome. It is also developing XP-8121, a once-weekly subcutaneous injection of levothyroxine that is in phase 3 clinical trial for the treatment of hypothyroidism. The company was incorporated in 2005 and is headquartered in Chicago, Illinois.
Sector:Healthcare
Industry:Biotechnology
Address:1375 West Fulton Street, Chicago, IL, United States, 60607
Website:https://www.xerispharma.com
CUSIP:98422L107
CIK:0001346302
ISIN:US98422E1038
FIGI:BBG012V1MG52

API SERVICE  NEW

Have you tried our new API Service yet?

For more information, visit our API page.

You can get your ApiKey over HERE.

If you're ready to get going, then jump over to:
https://api.eoddata.com

SYMBOL HISTORY

   Add to Watchlist

DOWNLOAD DATA

Download stock quote history quickly and easily in a variety of formats to suit your needs.

  Download

FUNDAMENTALS

Trailing P/E:-26.76 
Forward P/E:-44.55 
PEG Ratio:0.30 
Price to Sales:6.43 
Price to Book:-81.78 
Profit Margin:-0.13 
Operating Margin:0.06 
Return on Assets:-0.01 
Return on Equity:1.85 
EPS Ratio:-0.20 
Revenue:246.02M 
EBITDA:8.38M 
Shares:161.48M 
Market Cap:1.13B 

TECHNICAL INDICATORS

MA5:7.060.9%
MA10:6.980.3%
MA20:6.940.8%
MA50:7.9113.0%
MA100:7.699.8%
MA200:6.2412.2%
STO9:19.44 
STO14:65.06
RSI14:46.29
WPR14:-22.86
MTM14:0.05
ROC14:0.01 
ATR:0.31 
Week High:7.263.7%
Week Low:6.901.5%
Month High:7.304.3%
Month Low:6.4712.2%
Year High:10.0844.0%
Year Low:3.14122.9%